Search

Your search keyword '"Yao, Masahiro"' showing total 1,094 results
Start Over Author "Yao, Masahiro"
1,094 results on '"Yao, Masahiro"'

2. Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers

Author

Jikuya, Ryosuke, Murakami, Koichi, Nishiyama, Akira, Kato, Ikuma, Furuya, Mitsuko, Nakabayashi, Jun, Ramilowski, Jordan A., Hamanoue, Haruka, Maejima, Kazuhiro, Fujita, Masashi, Mitome, Taku, Ohtake, Shinji, Noguchi, Go, Kawaura, Sachi, Odaka, Hisakazu, Kawahara, Takashi, Komeya, Mitsuru, Shinoki, Risa, Ueno, Daiki, Ito, Hiroki, Ito, Yusuke, Muraoka, Kentaro, Hayashi, Narihiko, Kondo, Keiichi, Nakaigawa, Noboru, Hatano, Koji, Baba, Masaya, Suda, Toshio, Kodama, Tatsuhiko, Fujii, Satoshi, Makiyama, Kazuhide, Yao, Masahiro, Shuch, Brian M., Schmidt, Laura S., Linehan, W. Marston, Nakagawa, Hidewaki, Tamura, Tomohiko, and Hasumi, Hisashi

Published
2022
Full Text
View/download PDF

3. SETD2 regulates SLC family transporter-mediated sodium and glucose reabsorptions in renal tubule

Author

Mitome, Taku, primary, Wakui, Hiromichi, additional, Azushima, Kengo, additional, Uehara, Tatsuki, additional, Jikuya, Ryosuke, additional, Ohtake, Shinji, additional, Noguchi, Go, additional, Kawaura, Sachi, additional, Iribe, Yasuhiro, additional, Aomori, Kota, additional, Tatenuma, Tomoyuki, additional, Ito, Hiroki, additional, Kawahara, Takashi, additional, Komeya, Mitsuru, additional, Ito, Yusuke, additional, Muraoka, Kentaro, additional, Furuya, Mitsuko, additional, Kato, Ikuma, additional, Fujii, Satoshi, additional, Nagahama, Kiyotaka, additional, Nishiyama, Akira, additional, Tamura, Tomohiko, additional, Kimura, Yayoi, additional, Kawagoe, Tatsukata, additional, Mizuki, Nobuhisa, additional, Huang, Gang, additional, Uemura, Hiroji, additional, Yao, Masahiro, additional, Makiyama, Kazuhide, additional, Tamura, Kouichi, additional, and Hasumi, Hisashi, additional

Published
2024
Full Text
View/download PDF

8. Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis

Author

Hayashi, Narihiko, Osaka, Kimito, Muraoka, Kentaro, Hasumi, Hisashi, Makiyama, Kazuhide, Kondo, Keiichi, Nakaigawa, Noboru, Yao, Masahiro, Mukai, Yuki, Sugiura, Madoka, Takano, Shoko, Ito, Eiko, Kaizu, Hisashi, Koike, Izumi, Hata, Masaharu, Taguri, Masataka, Miyoshi, Yasuhide, Izumi, Koji, Kawahara, Takashi, and Uemura, Hiroji

Published
2020
Full Text
View/download PDF

15. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma

Author

Jikuya, Ryosuke, primary, Johnson, Todd A., additional, Maejima, Kazuhiro, additional, An, Jisong, additional, Ju, Young-Seok, additional, Lee, Hwajin, additional, Ha, Kyungsik, additional, Song, WooJeung, additional, Kim, Youngwook, additional, Okawa, Yuki, additional, Sasagawa, Shota, additional, Kanazashi, Yuki, additional, Fujita, Masashi, additional, Imoto, Seiya, additional, Mitome, Taku, additional, Ohtake, Shinji, additional, Noguchi, Go, additional, Kawaura, Sachi, additional, Iribe, Yasuhiro, additional, Aomori, Kota, additional, Tatenuma, Tomoyuki, additional, Komeya, Mitsuru, additional, Ito, Hiroki, additional, Ito, Yusuke, additional, Muraoka, Kentaro, additional, Furuya, Mitsuko, additional, Kato, Ikuma, additional, Fujii, Satoshi, additional, Hamanoue, Haruka, additional, Tamura, Tomohiko, additional, Baba, Masaya, additional, Suda, Toshio, additional, Kodama, Tatsuhiko, additional, Makiyama, Kazuhide, additional, Yao, Masahiro, additional, Shuch, Brian M., additional, Ricketts, Christopher J., additional, Schmidt, Laura S., additional, Linehan, W. Marston, additional, Nakagawa, Hidewaki, additional, and Hasumi, Hisashi, additional

Published
2023
Full Text
View/download PDF

16. Data from TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease

Author

Baba, Masaya, primary, Furuya, Mitsuko, primary, Motoshima, Takanobu, primary, Lang, Martin, primary, Funasaki, Shintaro, primary, Ma, Wenjuan, primary, Sun, Hong-Wei, primary, Hasumi, Hisashi, primary, Huang, Ying, primary, Kato, Ikuma, primary, Kadomatsu, Tsuyoshi, primary, Satou, Yorifumi, primary, Morris, Nicole, primary, Karim, Baktiar O., primary, Ileva, Lilia, primary, Kalen, Joseph D., primary, Wilan Krisna, Luh Ade, primary, Hasumi, Yukiko, primary, Sugiyama, Aiko, primary, Kurahashi, Ryoma, primary, Nishimoto, Koshiro, primary, Oyama, Masafumi, primary, Nagashima, Yoji, primary, Kuroda, Naoto, primary, Araki, Kimi, primary, Eto, Masatoshi, primary, Yao, Masahiro, primary, Kamba, Tomomi, primary, Suda, Toshio, primary, Oike, Yuichi, primary, Schmidt, Laura S., primary, and Linehan, W. Marston, primary

Published
2023
Full Text
View/download PDF

17. Supplemental Figure legends from TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease

Author

Baba, Masaya, primary, Furuya, Mitsuko, primary, Motoshima, Takanobu, primary, Lang, Martin, primary, Funasaki, Shintaro, primary, Ma, Wenjuan, primary, Sun, Hong-Wei, primary, Hasumi, Hisashi, primary, Huang, Ying, primary, Kato, Ikuma, primary, Kadomatsu, Tsuyoshi, primary, Satou, Yorifumi, primary, Morris, Nicole, primary, Karim, Baktiar O., primary, Ileva, Lilia, primary, Kalen, Joseph D., primary, Wilan Krisna, Luh Ade, primary, Hasumi, Yukiko, primary, Sugiyama, Aiko, primary, Kurahashi, Ryoma, primary, Nishimoto, Koshiro, primary, Oyama, Masafumi, primary, Nagashima, Yoji, primary, Kuroda, Naoto, primary, Araki, Kimi, primary, Eto, Masatoshi, primary, Yao, Masahiro, primary, Kamba, Tomomi, primary, Suda, Toshio, primary, Oike, Yuichi, primary, Schmidt, Laura S., primary, and Linehan, W. Marston, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figures and Tables from TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease

Author

Baba, Masaya, primary, Furuya, Mitsuko, primary, Motoshima, Takanobu, primary, Lang, Martin, primary, Funasaki, Shintaro, primary, Ma, Wenjuan, primary, Sun, Hong-Wei, primary, Hasumi, Hisashi, primary, Huang, Ying, primary, Kato, Ikuma, primary, Kadomatsu, Tsuyoshi, primary, Satou, Yorifumi, primary, Morris, Nicole, primary, Karim, Baktiar O., primary, Ileva, Lilia, primary, Kalen, Joseph D., primary, Wilan Krisna, Luh Ade, primary, Hasumi, Yukiko, primary, Sugiyama, Aiko, primary, Kurahashi, Ryoma, primary, Nishimoto, Koshiro, primary, Oyama, Masafumi, primary, Nagashima, Yoji, primary, Kuroda, Naoto, primary, Araki, Kimi, primary, Eto, Masatoshi, primary, Yao, Masahiro, primary, Kamba, Tomomi, primary, Suda, Toshio, primary, Oike, Yuichi, primary, Schmidt, Laura S., primary, and Linehan, W. Marston, primary

Published
2023
Full Text
View/download PDF

22. FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma

Author

Nakaigawa, Noboru, Kondo, Keiichi, Kaneta, Tomohiro, Tateishi, Ukihide, Minamimoto, Ryogo, Namura, Kazuhiro, Ueno, Daiki, Kobayashi, Kazuki, Kishida, Takeshi, Ikeda, Ichiro, Hasumi, Hisashi, Makiyama, Kazuhide, Hayashi, Narihiko, Osaka, Kimito, Muraoka, Kentaro, Izumi, Koji, Kawahara, Takashi, Teranishi, Jun-ichi, Miyoshi, Yasuhide, Yumura, Yasushi, Uemura, Hiroji, Inoue, Tomio, and Yao, Masahiro

Published
2018
Full Text
View/download PDF

23. Time-dependent change in relapse sites of renal cell carcinoma after curative surgery

Author

Noguchi, Go, Nakaigawa, Noboru, Taguri, Masataka, Tsutsumi, Sohgo, Saito, Yoko, Fukui, Sachi, Yasui, Masato, Tokita, Takashi, Mitome, Taku, Tatenuma, Tomoyuki, Kuroda, Shinnosuke, Abe, Koichi, Ueno, Daiki, Namura, Kazuhiro, Umemoto, Susumu, Takizawa, Akitoshi, Ohta, Junichi, Ueki, Teiichiro, Watanabe, Takeshi, Kobayashi, Kazuki, Kondo, Keiichi, Kishida, Takeshi, Kanno, Hitomi, Kitami, Kazuo, Yamanaka, Takeharu, and Yao, Masahiro

Published
2018
Full Text
View/download PDF

35. Data from Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma

Author

Morris, Mark R., primary, Gentle, Dean, primary, Abdulrahman, Mahera, primary, Maina, Esther N., primary, Gupta, Kunal, primary, Banks, Rosamonde E., primary, Wiesener, Michael S., primary, Kishida, Takeshi, primary, Yao, Masahiro, primary, Teh, Bin, primary, Latif, Farida, primary, and Maher, Eamonn R., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Table 1 from Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma

Author

Morris, Mark R., primary, Gentle, Dean, primary, Abdulrahman, Mahera, primary, Maina, Esther N., primary, Gupta, Kunal, primary, Banks, Rosamonde E., primary, Wiesener, Michael S., primary, Kishida, Takeshi, primary, Yao, Masahiro, primary, Teh, Bin, primary, Latif, Farida, primary, and Maher, Eamonn R., primary

Published
2023
Full Text
View/download PDF

42. Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Author

Tabei, Tadashi, Nakaigawa, Noboru, Kaneta, Tomohiro, Ikeda, Ichiro, Kondo, Keiichi, Makiyama, Kazuhide, Hasumi, Hisashi, Hayashi, Narihiko, Kawahara, Takashi, Izumi, Koji, Osaka, Kimito, Muraoka, Kentaro, Teranishi, Jun-ichi, Miyoshi, Yasuhide, Yumura, Yasushi, Uemura, Hiroji, Kobayashi, Kazuki, Inoue, Tomio, and Yao, Masahiro

Published
2019
Full Text
View/download PDF

44. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival

Author

Ito, Hiroki, Kondo, Keiichi, Kawahara, Takashi, Kaneta, Tomohiro, Tateishi, Ukihide, Ueno, Daiki, Namura, Kazuhiro, Kobayashi, Kazuki, Miyoshi, Yasuhide, Yumura, Yasushi, Makiyama, Kazuhide, Hayashi, Narihiko, Hasumi, Hisashi, Osaka, Kimito, Yokomizo, Yumiko, Teranishi, Jun-ichi, Hattori, Yusuke, Inoue, Tomio, Uemura, Hiroji, Yao, Masahiro, and Nakaigawa, Noboru

Published
2017
Full Text
View/download PDF

47. Screening for von Hippel-Lindau Disease by DNA Polymorphism Analysis

Author

Glenn, Gladys M, Linehan, W Marston, Hosoe, Shigeto, Latif, Farida, Yao, Masahiro, Choyke, Peter, Gorin, Michael B, Chew, Emily, Oldfield, Edward, Manolatos, Cia, Orcutt, Mary Lou, Walther, McClellan M, Weiss, Gary H, Tory, Kalman, Jensson, Olafur, Lerman, Michael I, and Zbar, Berton

Subjects
Biomedical and Clinical Sciences, Health Sciences, Rare Diseases, Prevention, Clinical Research, Genetics, Pediatric, Genetic Testing, Aetiology, 2.1 Biological and endogenous factors, Good Health and Well Being, DNA, Genetic Linkage, Humans, Pedigree, Polymorphism, Restriction Fragment Length, Prospective Studies, Risk, von Hippel-Lindau Disease, Medical and Health Sciences, General & Internal Medicine, Biomedical and clinical sciences, Health sciences
Abstract

ObjectiveVon Hippel-Lindau (VHL) disease is a rare, inherited multisystem neoplastic disorder. There is no biochemical test available to distinguish VHL disease gene carriers from their healthy siblings. We evaluated DNA polymorphism analysis as a method for identifying disease gene carriers.DesignProspective comparison of the results of DNA analysis with a comprehensive clinical screening examination.SettingThe Clinical Center of the National Institutes of Health.PatientsBlood was collected from 182 members of 16 families with VHL disease. Forty-eight asymptomatic individuals, at risk of developing this hereditary illness (with an affected parent or sibling), were examined for occult disease at the Clinical Center of the National Institutes of Health and tested by DNA polymorphism analysis.ResultsDNA polymorphism analysis predicted nine disease gene carriers and 33 individuals with the wild-type (normal) allele among the 48 individuals at risk of developing VHL disease; the test was not informative in six individuals. All nine individuals predicted to carry the VHL gene had evidence of occult disease on clinical examination. There was no clinical evidence of VHL disease in 32 of 33 individuals predicted to carry the wild-type allele.ConclusionsDNA polymorphism analysis can identify individuals likely to carry the VHL disease gene among asymptomatic members of disease families. This technique serves to focus attention on those individuals who require periodic medical examination and may help to alleviate the morbidity and mortality associated with this disease.

Published
1992

49. A Case of Lymphoepithelioma-Like Carcinoma of the Ureter

Author

FUJITA, Yuki, SUZUKI, Atsuto, ASAOKA, Miho, JIKUYA, Ryosuke, MITOME, Taku, OHTAKE, Shinji, TATENUMA, Tomoyuki, YAMANAKA, Hiroyuki, ITO, Yusuke, MURAOKA, Kentaro, MAKIYAMA, Kazuhide, KONDO, Keichi, NAKAIGAWA, Noboru, ENAKA, Makiko, and YAO, Masahiro

Subjects
494.9, Ureter, Lymphoepithelioma-like carcinoma
Abstract

Lymphoepithelioma-like carcinoma (LELC) of the ureter is very rare and only 14 previous cases have been reported. Here, we report a case of LELC of the ureter. A 76-year-old woman was admitted to our hospital complaining of gross hematuria. Left ureteral cancer was suspected by the imaging examination, and laparoscopic left total nephroureterectomy was performed. Histopathological examination showed pure type of LELC in the ureter. She is alive without disease recurrence at fifteen months after surgery.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results